Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Commissioner’s National Priority Voucher (CNPV)
Biotech
‘Real momentum’ or ‘absurd’? Trump stance shakes up psychedelics
The Trump administration's support could launch psychedelics across the regulatory finish line or doom the field to perpetual questions of legitimacy.
Darren Incorvaia
May 4, 2026 3:30am
Fierce Pharma
Regeneron ushers in new era with inaugural gene therapy approval
Apr 23, 2026 3:22pm
Trump orders FDA to fast-track reviews of psychedelic drugs
Apr 20, 2026 5:30am
Fierce Pharma
FDA solicits feedback on national priority voucher pilot
Mar 23, 2026 9:35am